Cannabix Technologies Inc. (BLOZF)
- Previous Close
0.4650 - Open
0.4500 - Bid 0.4490 x 1942500
- Ask 0.4658 x 5300000
- Day's Range
0.4500 - 0.4644 - 52 Week Range
0.2000 - 0.4970 - Volume
2,776 - Avg. Volume
86,158 - Market Cap (intraday)
52.621M - Beta (5Y Monthly) 3.07
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Aug 25, 2025 - Aug 29, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath systems, including cannabix mass spectrum (MS) breath sampler for mass spectrometers, optimized for breath collection and ionization that replaces the chromatography step and offers clinical and toxicology laboratories that analyzes nonvolatile species in breath; and cannabix breath collection unit that collects breath samples from the field onto a novel cartridge, which is taken and analyzed with the MS breath sampler. The company offers Breath Logix (BR-LGX), an industrial series a fully automated breath alcohol screening system for employee, contractor, and visitor access control that is self-administered, non-invasive, and has both non-contact and direct straw modes. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
cannabixtechnologies.comRecent News: BLOZF
更多內容Performance Overview: BLOZF
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
比較: BLOZF
選擇以關鍵表現數據分析類似公司;最多可選擇 4 個股份。
Statistics: BLOZF
更多內容Valuation Measures
Market Cap
52.50M
Enterprise Value
50.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
23.65
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-47.26%
Return on Equity (ttm)
-79.68%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.32M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
2.85M
Total Debt/Equity (mrq)
1.64%
Levered Free Cash Flow (ttm)
-1.53M